Motion Sickness Clinical Trial
Official title:
Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
Chronic motion sensitivity refers to a sensation of unwellness caused by physical or discerned motion and has a prevalence of 28% in the general population and it is more common in women (27.3%) compared to men. The investigators theorize that individuals with chronic motion sensitivity will have an impaired inner ear reflex and will be less physically active. Hence, the purpose of this study is to; 1. Determine whether the function of an inner ear reflex is different between young adults with/without chronic motion sensitivity 2. Assess relationships between reflex function and balance in young adults with/without CMS 3. Assess relationships between physical activity and balance in young adults with/without CMS.
Chronic motion sensitivity (CMS), also known as motion sickness, refers to a sensation of unwellness caused by physical or discerned motion. CMS has a prevalence of 28% in the general population and it is more common in women (27.3%) compared to men. Based on established evidence that individuals with chronic motion sensitivity demonstrate impaired postural stability with vestibular system impairment adjudged to be an inciting stimulus for chronic motion sensitivity, and individuals who practiced more physical and sporting activities have less motion sickness susceptibility than individuals who did not, the investigators theorize that individuals with chronic motion sensitivity will have an impaired inner ear reflex, causing them to be more reliant on other sensory systems like their muscles and joints, and their vision, we also theorize that individuals who are physically active will be less susceptible to chronic motion sensitivity. The purpose of this study is to; 1. Determine whether the function of an inner ear reflex is different between young adults with/without chronic motion sensitivity 2. Assess relationships between reflex function and balance in young adults with/without CMS 3. Assess relationships between physical activity and balance in young adults with/without CMS. Participants between the age of 20 and 40 with and without a self-reported history of chronic motion sensitivity (i.e, experiencing nauseousness and/or dizziness during while using various means of transportation such as, car, train, bus, boat, and airplane and/or, recreational fun-fair rides and/or when exposed to conflicting visual images). Participants will be excluded if they report a medical diagnosis of central nervous system disorder, impaired cervical spine range of motion, migraines, seizure disorder, vestibular dysfunction, or any musculoskeletal dysfunction that can limit their participation in the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
| Completed |
NCT05611814 -
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
|
N/A | |
| Recruiting |
NCT06106256 -
Three-Axis Wearable Adaptive Vestibular Stimulator
|
N/A | |
| Completed |
NCT02839135 -
A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.
|
Phase 1 | |
| Completed |
NCT04420949 -
Sensory Training for Visual Motion Sickness
|
N/A | |
| Completed |
NCT04184115 -
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
|
Phase 3 | |
| Completed |
NCT03988530 -
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
|
Phase 3 | |
| Terminated |
NCT04219982 -
DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
|
Phase 2/Phase 3 | |
| Terminated |
NCT02155309 -
Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray
|
Phase 2/Phase 3 | |
| Completed |
NCT04947423 -
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
|
Phase 3 | |
| Recruiting |
NCT05903924 -
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
|
Phase 3 | |
| Recruiting |
NCT04999449 -
Nebulizer Delivery of Intranasal Scopolamine
|
Phase 1 | |
| Recruiting |
NCT05886660 -
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
|
Phase 2 | |
| Completed |
NCT03755596 -
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
|
Phase 4 | |
| Recruiting |
NCT05628220 -
Motion Sickness Desensitization Using VR
|
N/A | |
| Recruiting |
NCT06138613 -
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
|
Phase 3 | |
| Completed |
NCT04327661 -
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
|
Phase 3 | |
| Completed |
NCT06232785 -
Gynecologic Endoscopic Surgery of Female Motion Sickness Patients
|
Phase 4 | |
| Completed |
NCT06056622 -
Motion Sickness Rehabilitation for Virtual Reality
|
N/A | |
| Withdrawn |
NCT04331561 -
Sensory Training for Orientation and Balance
|
N/A |